Search for stocks /

Thirumalai Chemicals:₹171 Share Price. Negative PAT ₹47 Cr. USA Plant Running. What Now?

Thirumalai Chemicals Q3 FY26 | EduInvesting
Q3 FY26 Results · Quarterly Results (Oct–Dec 2025)

Thirumalai Chemicals:
₹171 Share Price. Negative PAT ₹47 Cr. USA Plant Running. What Now?

Second-largest PAN producer in India, sole malic acid maker in Southeast Asia, and the USA plant started operations in December 2025. The only problem? The company is burning through cash, losing money every quarter, and the balance sheet looks like a Greek tragedy retold by a pessimistic accountant.

Market Cap₹2,066 Cr
CMP₹171
ROE-4.13%
Debt/Equity1.36x
Q3 PAT₹-47 Cr

The Chemistry of Crisis: A Company Caught Between Yesterday & Tomorrow

  • 52-Week High / Low₹329 / ₹158
  • Q3 FY26 Revenue₹416 Cr
  • Q3 FY26 PAT₹-47 Cr
  • TTM EPS₹-13.9
  • 9M FY26 PAT₹-140 Cr
  • Book Value / Share₹127
  • Price to Book1.36x
  • ROCE0.26%
  • Debt (Sep 2025)₹2,086 Cr
  • 3-Yr Stock CAGR-2.0%
Flash Summary: Thirumalai Chemicals is a tale of two companies. The old one — PAN manufacturing in India — is choking on bad spreads and margin pressure. The new one — a greenfield plant in West Virginia meant to produce higher-margin food acids and maleic anhydride — just started operations in Dec 2025, costing them ₹255 million (upgraded from ₹240 million), and won’t hit positive cash flow until maybe 2027-28. Meanwhile, the balance sheet shows debt at ₹2,086 crore and declining equity. ICRA downgraded them to BBB+ (Negative) in January 2026. The stock has crashed 44% in 6 months. And the management is betting everything on a company they’ve never run before, in a country they’ve never operated in, at a scale that’s absorbed their entire cash reserve.

The Slow-Motion Train Wreck That Chemistry Cannot Fix

Thirumalai Chemicals is not a startup. It’s been around since 1944 — when the Sampath family started a chemical trading house in Tamil Nadu. By the 1970s, they’d built a Phthalic Anhydride (PAN) facility in Ranipet that still runs today. They expanded into food acids in the 1990s, Malaysia in the 2000s, and in 2024 decided the logical next step was to build a ₹255-crore greenfield plant in West Virginia, USA. The stock price at the time? ₹329. Today? ₹171. That’s a 48% haircut in less than a year.

The company manufactures four main products: PAN (used for plasticizers and resins), Malic Acid (food and pharma), Fumaric Acid (food additives and inks), and Diethyl Phthalate (DEP, plasticizer). They ship to 60 countries and have customers like Reliance Industries (who supplies their raw material), Asian Paints, Parle, ITC, and Nerolac. On paper, this looks like a global chemicals powerhouse. In reality? The company lost ₹140 crores in nine months of FY26, is carrying ₹2,086 crores of debt, and the Malaysian facility is in the process of being divested because it’s bleeding cash. ICRA just dropped their rating by one full notch (from A- to BBB+) citing “weak PAN-OX spreads” and “liquidity stress.” Translation: they don’t have enough cash to service debt comfortably, and there’s no relief in sight.

The Merger & Acquisition Tea: In December 2025, the company closed a preferential allotment of 18,96,614 shares at ₹296 each, raising ₹56 crore from the promoter group. In other words: the family had to put their hand in their pocket to keep the company from running out of cash. That’s not a bullish signal. That’s triage.

They Make Chemicals. You Use Them Every Day. And You’ll Never Know They Exist.

Thirumalai Chemicals manufactures commodity chemicals — the industrial ingredients that go into paints, plasticizers, food additives, dyes, and resin-based products. They are not a brand. They will never sell you a bottle of anything at a supermarket. Their margin depends entirely on the spread between their raw material cost and their selling price. For PAN, that raw material is ortho-xylene (OX). For the food acids, it’s various feedstocks depending on the product.

The problem: they have virtually no pricing power. PAN is a commodity. If the price of OX spikes, their margin gets squeezed. If global PAN supply increases (which it has, with new plants in Korea and China coming online), they have to cut prices or lose volume. They’re competing against massive integrated players like Reliance (their own supplier, awkwardly), Chinese producers, and Korean manufacturers — all with lower costs. TCL tries to differentiate on quality and supply chain reliability. Spoiler: it doesn’t pay enough premium to offset commodity price volatility.

Product mix FY25: PAN is 85% of revenue. Everything else — Maleic Anhydride, downstream esters, food acids — is 15%. So they’re essentially a one-product company with some side hustles. And that one product’s profitability moves with the PAN-OX spread, which moves with crude oil prices, which means TCL’s earnings are held hostage to every OPEC decision.

PAN Mix85%revenue — too high
Manufacturing Capacity1,95,000 TPAacross 3 plants
Export Mix60%Europe + Americas
PAN-OX Spread↓ Negativeas of Q3
Fun fact: Thirumalai is the second-largest PAN producer in India, and among the top 3 globally. They’re the sole producer of Malic Acid in Southeast Asia. On any other day in any other company, that would be a moat worth celebrating. But when your primary product is getting murdered by global oversupply and your cost structure is locked in via long-term supplier contracts, being the “largest” is just being the largest to bleed.

Q3 FY26: The Quarterly Report That Reads Like a Suicide Note

error: Content is protected !!
Verified by MonsterInsights